Testing effectiveness (Phase 2)Study completedNCT00356122
What this trial is testing
Docetaxel & Oxaliplatin in Combination With Bevacizumab as First-Line Treatment in Subjects With Non-Small Cell Lung Cancer (NSCLC)
Who this might be right for
Non-Small Cell Lung Cancer
Sanofi 53